AME Company for Medical Supplies posted a net profit rise of 35.5% to SAR 45.4 million in 2024 from SAR 33.5 million in 2023.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 220.01 | 248.35 | 12.9 % |
Gross Income | 95.45 | 102.16 | 7.0 % |
Operating Income | 33.18 | 45.16 | 36.1 % |
Net Income | 33.52 | 45.40 | 35.5 % |
Average Shares | 7.00 | 7.00 | - |
Earnings Per Share before unusual items (Riyals) | 4.79 | 6.49 | 35.5 % |
EPS (Riyal) | 4.79 | 6.49 | 35.5 % |
The profit growth was attributed to higher sales of medical supplies and devices by SAR 28.34 million.
This increase resulted from the company's acquisition of a larger market share, which reflected growth in sales driven by increased market demand and effective sales strategies by acquiring new customers and introducing new products to the same existing customers.
In addition, AME intensified advertising and marketing efforts and hired additional staff in sales and marketing departments to ensure better coverage and faster customer response.
Moreover, the company saw an improvement in the provision for expected credit losses related to customers, while also effectively managing the increase in indirect expenses.
Item | H2 2023 | H2 2024 | Change |
---|---|---|---|
Revenues | 99.68 | 114.53 | 14.9 % |
Gross Income | 39.76 | 43.61 | 9.7 % |
Operating Income | 9.16 | 17.38 | 89.6 % |
Net Income | 11.32 | 18.81 | 66.2 % |
Average Shares | 7.00 | 7.00 | - |
Earnings Per Share before unusual items (Riyal) | 1.62 | 2.69 | 66.2 % |
EPS (Riyal) | 1.62 | 2.69 | 66.2 % |
Item | H1 2024 | H2 2024 | Change |
---|---|---|---|
Revenues | 133.82 | 114.53 | (14.4 %) |
Gross Income | 58.55 | 43.61 | (25.5 %) |
Operating Income | 27.78 | 17.38 | (37.4 %) |
Net Income | 26.59 | 18.81 | (29.3 %) |
Average Shares | 7.00 | 7.00 | - |
Earnings Per Share before unusual items (Riyal) | 3.80 | 2.69 | (29.3 %) |
EPS (Riyal) | 3.80 | 2.69 | (29.3 %) |
In H2 2024, the company’s net profit surged 66.2% YoY to SAR 18.81 million, from SAR 11.32 million in H2 2023.
On a sequential basis, net earnings dropped 29.3% from SAR 26.59 million in H1 2024.
Shareholders’ equity, no minority interest, reached SAR 158.82million as of Dec. 31, 2024, up from SAR 127.16 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: